Skip to content

Conventional Versus Point-of-care Based Coagulation Management

Conventional Versus Point-of-care Based Coagulation Management in Cardiac Surgery Patients Suffering From Increased Bleeding Tendency - a Prospective and Randomized Study

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00997841
Enrollment
200
Registered
2009-10-19
Start date
2009-06-30
Completion date
2010-04-30
Last updated
2010-05-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiac Surgery, Coagulation Management

Keywords

POC, ROTEM, Multiplate, bleeding tendency, coagulation management, amount of transfused red blood cell concentrates,, FFP, platelet concentrates, rate of rethoracotomy, ventilation time

Brief summary

The purpose of the study is to determine the efficacy of two different algorithms for coagulation management in patients undergoing cardiac surgery suffering from increased bleeding tendency. Algorithm 1 is based on conventional coagulation analyses (INR, aPTT, platelet count, fibrinogen concentration,...) and Algorithm 2 is based on thrombelastometry using the ROTEM-device and impedance aggregometry using the Multiplate device.

Interventions

PROCEDUREPoint-of-Care versus conventional coagulation management

Patients are randomized to receive either point-of-care based or conventional coagulation measurements based coagulation therapy in the case of increased perioperative bleeding tendency

Sponsors

University Hospital, Essen
CollaboratorOTHER
Goethe University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* age \> 18 years, combined surgical procedures (ACB & valve surgery), double valve surgery, aortic surgery, Re-Dos

Exclusion criteria

* none

Design outcomes

Primary

MeasureTime frame
amount of transfused red blood cell concentrates24 h after begin of surgical intervention

Secondary

MeasureTime frame
other transfused blood products including FFP, platelet concentrates and coagulation factor concentrates24h after surgical intervention
rate of rethoracotomy for bleeding24h after surgical intervention
ventilation time on ICUtill discharge from ICU

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026